Skip to content
SHM Abstracts | Society of Hospital Medicine Logo
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
  • Home
  • Meetings Archive
  • Browse By Category
  • Browse By Keyword
  • Search
Search2020-05-20T12:01:36-05:00
Search
Search by Abstract Number, Title, Keyword, or Authors
Category
Sub-Category

(Optional)

Session Type
Meeting
Search Results
Plenary Presentations
Abstract Number: 0002
DO ENCOUNTERS WITH A FIELD-BASED HOMELESS HEALTHCARE TEAM IMPROVE CHRONIC DISEASE CONTROL AND REDUCE ACUTE CARE UTILIZATION FOR PEOPLE EXPERIENCING HOMELESSNESS IN LOS ANGELES COUNTY?
SHM Converge 2025
Background: People experiencing homelessness (PEH) face barriers to accessing regular ambulatory care, which increases their risk of having poorly controlled chronic medical conditions and contributes to high acute care utilization. The role of field-based homeless healthcare teams in improving hypertension and diabetes control and reducing acute care utilization (e.g., emergency department [ED] visits, inpatient hospitalizations) [...]
Oral Presentations
Abstract Number: 0006
IMPACT OF CLINICIAN CARE TEAM MODEL ON RISK OF DIAGNOSTIC ERRORS AMONG ADULTS WHO TRANSFERRED TO INTENSIVE CARE OR DIED
SHM Converge 2025
Background: Diagnostic errors (DEs), or the failure to accurately identify or provide timely explanations of a patient’s health problem, are a significant source of patient harm. DEs occur in up to 23% of adult inpatients who transfer to intensive care units (ICU) or die. Few studies have examined how clinician team composition impacts DE risk. [...]
Oral Presentations
Abstract Number: 0007
PRIOR GLP-1 AGONIST USE IS NOT ASSOCIATED WITH ADVERSE INPATIENT QUALITY OUTCOMES: A PROPENSITY-MATCHED ANALYSIS
SHM Converge 2025
Background: Glucagon-like peptide-1 (GLP-1) agonists are increasingly prescribed for obesity and type 2 diabetes, demonstrating efficacy in weight loss and glycemic control [1-3]. Beyond metabolic effects, these medications show protective effects against renal disease progression and reduce major adverse cardiovascular events [4]. GLP-1 agonists influence body composition through effects on both fat mass and fat-free [...]
Plenary Presentations
Abstract Number: 0002
DO ENCOUNTERS WITH A FIELD-BASED HOMELESS HEALTHCARE TEAM IMPROVE CHRONIC DISEASE CONTROL AND REDUCE ACUTE CARE UTILIZATION FOR PEOPLE EXPERIENCING HOMELESSNESS IN LOS ANGELES COUNTY?
SHM Converge 2025
Background: People experiencing homelessness (PEH) face barriers to accessing regular ambulatory care, which increases their risk of having poorly controlled chronic medical conditions and contributes to high acute care utilization. The role of field-based homeless healthcare teams in improving hypertension and diabetes control and reducing acute care utilization (e.g., emergency department [ED] visits, inpatient hospitalizations) [...]
Oral Presentations
Abstract Number: 0006
IMPACT OF CLINICIAN CARE TEAM MODEL ON RISK OF DIAGNOSTIC ERRORS AMONG ADULTS WHO TRANSFERRED TO INTENSIVE CARE OR DIED
SHM Converge 2025
Background: Diagnostic errors (DEs), or the failure to accurately identify or provide timely explanations of a patient’s health problem, are a significant source of patient harm. DEs occur in up to 23% of adult inpatients who transfer to intensive care units (ICU) or die. Few studies have examined how clinician team composition impacts DE risk. [...]
Oral Presentations
Abstract Number: 0007
PRIOR GLP-1 AGONIST USE IS NOT ASSOCIATED WITH ADVERSE INPATIENT QUALITY OUTCOMES: A PROPENSITY-MATCHED ANALYSIS
SHM Converge 2025
Background: Glucagon-like peptide-1 (GLP-1) agonists are increasingly prescribed for obesity and type 2 diabetes, demonstrating efficacy in weight loss and glycemic control [1-3]. Beyond metabolic effects, these medications show protective effects against renal disease progression and reduce major adverse cardiovascular events [4]. GLP-1 agonists influence body composition through effects on both fat mass and fat-free [...]
Abstract Number: 0019
COMPARING METHODS FOR ATTRIBUTING HOSPITAL QUALITY METRICS TO INDIVIDUAL HOSPITALISTS: A RETROSPECTIVE COHORT STUDY
SHM Converge 2025
Background: Accurate attribution of quality metrics to individual hospitalists is crucial for quality improvement and value-based care initiatives. However, the collaborative nature of inpatient care with frequent patient handoffs makes fair attribution challenging. The current understanding of variation in hospitalist quality metrics comes primarily from studies using attribution methods based on who oversaw the majority [...]
Abstract Number: 0020
SCREENING AND TREATMENT FOR UNHEALTHY ALCOHOL USE DURING HOSPITALIZATION
SHM Converge 2025
Background: Screening and treatment for unhealthy alcohol use (UAU) and alcohol use disorder (AUD) is recommended but underutilized, particularly in inpatient settings. Initiating interventions during hospitalization can reduce UAU and may improve clinical outcomes. Methods: We implemented screening and treatment for UAU at a safety-net hospital in Austin, Texas. Nurses screen admitted patients with the [...]
Abstract Number: 0105
CANCER CARE INEQUITIES IN THE FACE OF MENTAL HEALTH AND SUBSTANCE CHALLENGES IN UNDERSERVED COMMUNITIES
SHM Converge 2025
Background: Substance use and mental health disorders significantly contribute to disparities in cancer care, particularly in the South Bronx, a region with a large Latinx and Black population. This study evaluates the impact of these disorders on cancer care among newly diagnosed patients at Lincoln Cancer Center. Methods: This retrospective study included newly diagnosed cancer [...]
Abstract Number: 0106
REGIONAL DIFFERENCES BETWEEN NORTHEAST AND SOUTHERN HOSPITALIZATIONS FOR PATIENTS ADMITTED WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
SHM Converge 2025
Background: Chronic Obstructive Pulmonary Disease (COPD) exacerbations result in significant morbidity, mortality, and healthcare costs. Understanding regional differences in clinical outcomes and healthcare utilization among patients hospitalized with COPD may provide insight into best practices in caring for this vulnerable patient population. Methods: Using the National Inpatient Sample (NIS) database for the years 2016 to [...]
1 2 3 … 6 Next ›
  • This Week

  • This Month

  • All Time

  • This Week

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • This Month

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • NALTREXONE – INDUCED KRATOM WITHDRAWAL: A CALL FOR AWARENESS

  • A CASE OF AMANTADINE INDUCED LIVEDO RETICULARIS IN A PATIENT WITH MULTIPLE SCLEROSIS

  • LOSARTAN-INDUCED ELECTROLYTE DEPLETION

  • Cannabis Withdrawal Induced Hypertensive Urgency

  • All Time

  • FEEDBACK THAT WORKS: IMPROVED BILLING THROUGH AUTOMATED PEER COMPARISON

  • ADDERALL INDUCED ISCHEMIC COLITIS

  • A CASE OF SKIN NECROSIS CAUSED BY INTRAVENOUS XYLAZINE ABUSE

  • Bc Powder Causing Intracerebral Bleed: Pitfalls of Overlooking Dosage of Seemingly Innocuous Otc Formulations

  • RECOGNIZING S1Q3T3 FOR WHAT IT IS: A NONSPECIFIC PATTERN OF RIGHT HEART STRAIN

© Society of Hospital Medicine | All Rights Reserved | Privacy Policy
Page load link
Go to Top